Compare FLXS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLXS | SMTI |
|---|---|---|
| Founded | 2001 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.8M | 186.9M |
| IPO Year | N/A | N/A |
| Metric | FLXS | SMTI |
|---|---|---|
| Price | $40.48 | $24.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 27.7K | ★ 42.5K |
| Earning Date | 02-02-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | ★ 64.53 | N/A |
| EPS | ★ 4.11 | N/A |
| Revenue | ★ $447,505,000.00 | $101,877,532.00 |
| Revenue This Year | $4.11 | $21.60 |
| Revenue Next Year | $3.04 | $16.70 |
| P/E Ratio | $9.98 | ★ N/A |
| Revenue Growth | 6.00 | ★ 30.52 |
| 52 Week Low | $29.38 | $18.90 |
| 52 Week High | $64.14 | $38.68 |
| Indicator | FLXS | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 54.61 | 53.80 |
| Support Level | $38.57 | $22.60 |
| Resistance Level | $41.43 | $25.96 |
| Average True Range (ATR) | 1.38 | 0.94 |
| MACD | -0.10 | 0.10 |
| Stochastic Oscillator | 71.88 | 61.70 |
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.